JPRN-UMIN000020352已完成未知
Efficacy of quadrivalent human papillomavirus vaccine (Gardasil) for recurrent respiratoru papillomatosis - Quadrivalent human papillomavirus vaccine (Gardasil) for recurrent respiratoru papillomatosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with severe renal or liver dysfunction, with a risk for general anesthesia, or whom a doctor considered not eligible
研究者
相似试验
招募中
不适用
The efficacy evaluation of the human papillomavirus (HPV) testing in primary cervix cancer screeningCervix cancerJPRN-UMIN000014720School of Medicine, Keio University50,000
已完成
不适用
The Canadian Cervical Cancer Screening Trial of human papillomavirus (HPV) testing versus Pap cytologyCancerISRCTN57612064McGill University (Canada) - Research Grants Office10,154
进行中（未招募）
1 期
HIPvac: a trial of vaccination and topical treatment in patients with anogenital wartsAnogenital wartsMedDRA version: 20.1 Level: PT Classification code 10059313 Term: Anogenital warts System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10018182 Term: Genital warts System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-002951-14-GBniversity College London503
已完成
不适用
Efficacy of addition of high-risk human papillomavirus (hrHPV) testing by Hybrid Capture II to conventional cytological screening for cervical cancerCervical intraepithelial neoplasiaCarcinoma in situ of cervix uteriCancerISRCTN64621295SALTRO - Doctor Laboratory & Thrombosis Service (The Netherlands)25,000
终止
1 期
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young AdultsHuman Immunodeficiency VirusHuman Papillomavirus- 6, 11, 16, 18AdolescentPapillomavirus VaccinesNCT00798265National Cancer Institute (NCI)26